Literature DB >> 20845004

Expressions of hypoxia-inducible factor-1α and hexokinase-II in gastric adenocarcinoma: the impact on prognosis and correlation to clinicopathologic features.

Miao-Zhen Qiu1, Bing Han, Hui-Yan Luo, Zhi-Wei Zhou, Zhi-Qiang Wang, Feng-Hua Wang, Yu-Hong Li, Rui-Hua Xu.   

Abstract

The impact of hypoxia-inducible factor (HIF)-1α and hexokinase-II (HK-II) expression on prognosis of gastric adenocarcinoma patients has not been clearly established. We identified all patients in Cancer Center of Sun Yat-Sen University who were diagnosed as gastric adenocarcinoma and underwent radical gastrectomy between January 1999 and December 2001. We used immunohistochemistry to determine the expressions of HIF-1α protein and HK-II in the surgical sections. We identified 188 patients with gastric adenocarcinoma for the final analysis. The positive rate of HIF-1α and HK-II were 110/188 (54.6%) and 40/188 (21.3%), respectively. Both HIF-1α and HK-II were all positively correlated with tumor size, lower differentiation, and tumor stage. Univariate analysis showed that advanced tumor stages (P < 0.001), tumor size (P = 0.003), HIF-1α expression (P < 0.001), and HK-II expression (P < 0.001) were all significantly associated with shorter survival. The multivariate Cox analysis revealed that tumor stage (P < 0.001), HIF-1α expression (P < 0.001), and HK-II expression (P = 0.002) remained independent prognostic variables for survival. In addition, there was a positive correlation of HIF-1α protein expression and HK-II (P = 0.022). Both HIF-1α and HK-II were overexpressed in gastric adenocarcinoma. The multivariate Cox analysis revealed that both of them were independent factors on survival of gastric adenocarcinoma patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20845004     DOI: 10.1007/s13277-010-0109-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  37 in total

1.  COMPARATIVE BIOCHEMISTRY HEPATOMAS. IV. ISOTOPE STUDIES OF GLUCOSE AND FRUCTOSE METABOLISM IN LIVER TUMORS OF DIFFERENT GROWTH RATES.

Authors:  M J SWEENEY; J ASHMORE; H P MORRIS; G WEBER
Journal:  Cancer Res       Date:  1963-08       Impact factor: 12.701

2.  Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis.

Authors:  P Birner; B Gatterbauer; G Oberhuber; M Schindl; K Rössler; A Prodinger; H Budka; J A Hainfellner
Journal:  Cancer       Date:  2001-07-01       Impact factor: 6.860

3.  Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy.

Authors:  R A Gatenby; H B Kessler; J S Rosenblum; L R Coia; P J Moldofsky; W H Hartz; G J Broder
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-05       Impact factor: 7.038

4.  Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation.

Authors:  G Helmlinger; F Yuan; M Dellian; R K Jain
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

5.  Differences in expression and intracellular distribution of hexokinase isoenzymes in rat liver cells of different transformation stages.

Authors:  A Rempel; P Bannasch; D Mayer
Journal:  Biochim Biophys Acta       Date:  1994-11-22

6.  Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis.

Authors:  R Bos; H Zhong; C F Hanrahan; E C Mommers; G L Semenza; H M Pinedo; M D Abeloff; J W Simons; P J van Diest; E van der Wall
Journal:  J Natl Cancer Inst       Date:  2001-02-21       Impact factor: 13.506

Review 7.  The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.

Authors:  J M Brown; A J Giaccia
Journal:  Cancer Res       Date:  1998-04-01       Impact factor: 12.701

8.  Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy.

Authors:  M I Koukourakis; A Giatromanolaki; J Skarlatos; L Corti; S Blandamura; M Piazza; K C Gatter; A L Harris
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

9.  Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention.

Authors:  Peter L Pedersen; Saroj Mathupala; Annette Rempel; J F Geschwind; Young Hee Ko
Journal:  Biochim Biophys Acta       Date:  2002-09-10

10.  Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma.

Authors:  D M Brizel; S P Scully; J M Harrelson; L J Layfield; J M Bean; L R Prosnitz; M W Dewhirst
Journal:  Cancer Res       Date:  1996-03-01       Impact factor: 12.701

View more
  23 in total

1.  Reduced survival of patients with hepatocellular carcinoma expressing hexokinase II.

Authors:  Lei Gong; Zhuqingqing Cui; Pengcheng Chen; Hui Han; Jirun Peng; Xisheng Leng
Journal:  Med Oncol       Date:  2011-01-30       Impact factor: 3.064

Review 2.  Prognostic value of HIF-1α expression in patients with gastric cancer.

Authors:  Cheng-lin Zhu; Qiang Huang; Chen-hai Liu; Xian-sheng Lin; Fang Xie
Journal:  Mol Biol Rep       Date:  2013-09-23       Impact factor: 2.316

3.  Comparison of site-specific gene expression levels in primary tumors and synchronous lymph node metastases in advanced gastric cancer.

Authors:  Akira Naruke; Mizutomo Azuma; Atsuko Takeuchi; Kenji Ishido; Chikatoshi Katada; Tohru Sasaki; Katsuhiko Higuchi; Satoshi Tanabe; Makoto Saegusa; Wasaburo Koizumi
Journal:  Gastric Cancer       Date:  2014-03-21       Impact factor: 7.370

4.  Improved vascular organization enhances functional integration of engineered skeletal muscle grafts.

Authors:  Jacob Koffler; Keren Kaufman-Francis; Yulia Shandalov; Shandalov Yulia; Dana Egozi; Egozi Dana; Daria Amiad Pavlov; Amiad Pavlov Daria; Amir Landesberg; Shulamit Levenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-30       Impact factor: 11.205

Review 5.  Glucose metabolism in gastric cancer: The cutting-edge.

Authors:  Lian-Wen Yuan; Hiroharu Yamashita; Yasuyuki Seto
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

Review 6.  Meta-analysis of immunohistochemical expression of hypoxia inducible factor-1α as a prognostic role in gastric cancer.

Authors:  Shuang Lin; Rui Ma; Xue-Yong Zheng; Hong Yu; Xiao Liang; Hui Lin; Xiu-Jun Cai
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

7.  Hypoxia-inducible factor-1α (HIF-1α) C1772T polymorphism significantly contributes to the risk of malignancy from a meta-analysis.

Authors:  Gang Wu; Wen-Feng Yan; Yuan-Zeng Zhu; Pei-Chun Sun
Journal:  Tumour Biol       Date:  2014-01-15

8.  The role of Aurora A in hypoxia-inducible factor 1α-promoting malignant phenotypes of hepatocelluar carcinoma.

Authors:  Shi-Yun Cui; Jia-Yuan Huang; Yi-Tian Chen; Hai-Zhu Song; Gui-Chun Huang; Wei De; Rui Wang; Long-Bang Chen
Journal:  Cell Cycle       Date:  2013-08-07       Impact factor: 4.534

Review 9.  Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio.

Authors:  Marike W van Gisbergen; Emma Zwilling; Ludwig J Dubois
Journal:  Front Oncol       Date:  2021-05-10       Impact factor: 6.244

10.  Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in China.

Authors:  Miao-zhen Qiu; Mu-yan Cai; Dong-sheng Zhang; Zhi-qiang Wang; De-shen Wang; Yu-hong Li; Rui-hua Xu
Journal:  J Transl Med       Date:  2013-03-06       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.